Identification of the origin of brain metastases based on the relative methylation orderings of CpG sites

References

• Barnholtz-Sloan JS, Sloan AE, Davis FG, et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan detroit cancer surveillance system. J Clin Oncol. 2004;22(14):2865–2872. .
   Google Scholar
• Nayak L, Lee EQ, Wen PY. Epidemiology of brain metastases. Curr Oncol Rep. 2012;14(1):48–54.
   Google Scholar
• Rostami R, Mittal S, Rostami P, et al. Brain metastasis in breast cancer: a comprehensive literature review. J Neurooncol. 2016;127(3):407–414. .
   Google Scholar
• Berghoff AS, Schur S, Fureder LM, et al. Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers. ESMO Open. 2016;1(2):e000024. .
   Google Scholar
• Ali A, Goffin JR, Arnold A, et al. Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases. Curr Oncol. 2013;20(4):e300–306. .
   Google Scholar
• Spagnolo F, Picasso V, Lambertini M, et al. Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: A systematic review. Cancer Treat Rev. 2016;45:38–45.
   Google Scholar
• Lin X, DeAngelis LM. Treatment of Brain Metastases. J Clin Oncol. 2015;33(30):3475–3484.
   Google Scholar
• Hardesty DA, Nakaji P. The Current and Future Treatment of Brain Metastases. Front Surg. 2016;3:30.
   Google Scholar
• Ahluwalia MS, Vogelbaum MV, Chao ST, et al. Brain metastasis and treatment. F1000Prime Rep. 2014;6:114.
   Google Scholar
• Pekmezci M, Perry A. Neuropathology of brain metastases. Surg Neurol Int. 2013;4(5):S245–255.
   Google Scholar
• Bekaert L, Emery E, Levallet G, et al. Histopathologic diagnosis of brain metastases: current trends in management and future considerations. Brain Tumor Pathol. 2017;34:8–19.
   Google Scholar
• Anderson GG, Weiss LM. Determining tissue of origin for metastatic cancers: meta-analysis and literature review of immunohistochemistry performance. Appl Immunohistochem Mol Morphol. 2010;18(1):3–8.
   Google Scholar
• Hao X, Luo H, Krawczyk M, et al. DNA methylation markers for diagnosis and prognosis of common cancers. Proc Natl Acad Sci U S A. 2017;114(28):7414–7419.
   Google Scholar
• Ding W, Chen G, Shi T. Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis. Epigenetics. 2019;14(1):67–80.
   Google Scholar
• Capper D, Jones DTW, Sill M, et al. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555:469–474.
   Google Scholar
• Karimi S, Zuccato JA, Mamatjan Y, et al. The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care. Clin Epigenetics. 2019;11:185.
   Google Scholar
• Moran S, Martinez-Cardus A, Sayols S, et al. Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis. Lancet Oncol. 2016;17(10):1386–1395. .
   Google Scholar
• Jurmeister P, Bockmayr M, Seegerer P, et al. Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases. Sci Transl Med. 2019;11(509):eaaw8513.
   Google Scholar
• Barciszewska AM. Global DNA demethylation as an epigenetic marker of human brain metastases. Biosci Rep. 2018;38(5):BSR20180731.
   Google Scholar
• Euskirchen P, Bielle F, Labreche K, et al. Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing. Acta Neuropathol. 2017;134(5):691–703. .
   Google Scholar
• Baettig F, Vlajnic T, Vetter M, et al. Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response. J Immunother Cancer 2019; 7:281.
   Google Scholar
• Haefliger S, Tzankov A, Frank S, et al. NUT midline carcinomas and their differentials by a single molecular profiling method: a new promising diagnostic strategy illustrated by a case report. Virchows Arch. 2020.
   Google Scholar
• Cheng J, Guo Y, Gao Q, et al. Circumvent the uncertainty in the applications of transcriptional signatures to tumor tissues sampled from different tumor sites. Oncotarget. 2017;8(18):30265–30275. .
   Google Scholar
• Guan Q, Zeng Q, Yan H, et al. A qualitative transcriptional signature for the early diagnosis of colorectal cancer. Cancer Sci. 2019;110:3225–3234.
   Google Scholar
• Chen R, Guan Q, Cheng J, et al. Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples. Oncotarget. 2017;8(4):6652–6662. .
   Google Scholar
• Xu L, Tan AC, Winslow RL, et al. Merging microarray data from separate breast cancer studies provides a robust prognostic test. BMC Bioinformatics. 2008;9(1):125. .
   Google Scholar
• Guan Q, Yan H, Chen Y, et al. Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer. BMC Genomics. 2018;19(1):99. .
   Google Scholar
• Ao L, Song X, Li X, et al. An individualized prognostic signature and multiomics distinction for early stage hepatocellular carcinoma patients with surgical resection. Oncotarget. 2016;7:24097–24110.
   Google Scholar
• Li H, Hong G, Xu H, et al. Application of the rank-based method to DNA methylation for cancer diagnosis. Gene. 2015;555(2):203–207. .
   Google Scholar
• Udali S, De Santis D, Ruzzenente A, et al. DNA methylation and hydroxymethylation in primary colon cancer and synchronous hepatic metastasis. Front Genet. 2017;8:229.
   Google Scholar
• Ju HX, An B, Okamoto Y, et al. Distinct profiles of epigenetic evolution between colorectal cancers with and without metastasis. Am J Pathol. 2011;178:1835–1846.
   Google Scholar
• Maaten LVD, Hinton G. Visualizing data using t-SNE. J Mach Learn Res. 2008;9:2579–2605.
   Google Scholar
• McInnes L, Healy J, Melville J. Umap: uniform manifold approximation and projection for dimension reduction. arXiv Preprint. 2018;arXiv:180203426.
   Google Scholar
• Cassandri M, Butera A, Amelio I, et al. ZNF750 represses breast cancer invasion via epigenetic control of prometastatic genes. Oncogene. 2020;39:4331–4343.
   Google Scholar
• Orozco JIJ, Knijnenburg TA, Manughian-Peter AO, et al. Epigenetic profiling for the molecular classification of metastatic brain tumors. Nat Commun. 2018;9:4627.
   Google Scholar
• Murillo MM, Rana S, Spencer-Dene B, et al. Disruption of the interaction of RAS with PI 3-kinase induces regression of EGFR-mutant-driven lung cancer. Cell Rep. 2018;25(13):3545–3553 e3542. .
   Google Scholar
• Feber A, Guilhamon P, Lechner M, et al. Using high-density DNA methylation arrays to profile copy number alterations. Genome Biol. 2014;15(2):R30. .
   Google Scholar
• Salhia B, Kiefer J, Ross JT, et al. Integrated genomic and epigenomic analysis of breast cancer brain metastasis. PLoS One. 2014;9:e85448.
   Google Scholar
• Troyanskaya O, Cantor M, Sherlock G, et al. Missing value estimation methods for DNA microarrays. Bioinformatics. 2001;17(6):520–525. .
   Google Scholar
• Liaw A, Wiener M. Classification and regression by randomForest. R News. 2002;2:18–22.
   Google Scholar